ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2023

Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY).

Clara G Chisari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.